SZSE:300529 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SZSE:300529 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Jafron Biomedical Co's sale of property, plant, equipment for the three months ended in Sep. 2024 was ¥5 Mil. It means Jafron Biomedical Co gained ¥5 Mil from selling property, plant, and equipment. Jafron Biomedical Co's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥5 Mil.
Compared with last quarter (¥0 Mil in Jun. 2024 ), Jafron Biomedical Co gained more money from selling property, plant, and equipment in Sep. 2024 (¥5 Mil).
The historical data trend for Jafron Biomedical Co's Sale Of Property, Plant, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jafron Biomedical Co Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Sale Of Property, Plant, Equipment | Get a 7-Day Free Trial | 0.02 | 0.81 | 0.99 | 6.91 | 12.60 |
Jafron Biomedical Co Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Sale Of Property, Plant, Equipment | Get a 7-Day Free Trial | 2.74 | 0.58 | 0.07 | - | 4.82 |
The amount earned to sell PPE.
Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Jafron Biomedical Co's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.
Li Feng | Director | |
He Xiao Lian | Executives | |
Dong Fan | Directors, Directors, and Executives | |
Ceng Kai | Directors, executives | |
Tang Xian Min | Directors, executives | |
Zhang Ming Yuan | Secretary Dong | |
Fang Li Hua | Supervisors | |
Zhang Guang Hai | Directors, executives | |
Li De Zhi | Executives | |
Lu Shao Zhang | Executives |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.